In Vitro Diagnostic Packaging Market Report 2026

In Vitro Diagnostic Packaging Market Overview

• In Vitro Diagnostic Packaging market size has reached to $10.04 billion in 2025 • Expected to grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Rising Prevalence Of Chronic And Infectious Diseases Fueling The Market Due To Increasing Diagnostic Needs • Market Trend: Advancing Sustainability In IVD Packaging With Eco-Friendly Innovations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under In Vitro Diagnostic Packaging Market?

In vitro diagnostic (IVD) packaging refers to specialized materials and containers developed to store, protect, and transport IVD devices. These devices conduct tests on biological samples, such as blood or tissue, to diagnose diseases or monitor health conditions. Effective packaging is crucial for maintaining the integrity and reliability of these devices throughout their lifecycle, protecting them from contamination, damage, and environmental factors. The main packaging types in in vitro diagnostic packaging are primary packaging, secondary packaging, and tertiary packaging. Primary packaging in in vitro diagnostic (IVD) packaging refers to the immediate container or material that directly encloses and protects the diagnostic product, ensuring its integrity, safety, and functionality before use. The products in this are bottles and vials, tubes, petri dishes, closures, and others made with material types including plastic, glass, metal, and composite materials, which are used in application areas such as biochemistry, microbiology, immunology, and molecular diagnostics by the end user, including hospitals, laboratories, academic institutes, and others.

What Is The In Vitro Diagnostic Packaging Market Growth Forecast?

The in vitro diagnostic packaging market size is expected to see strong growth in the next few years. It will grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing growth of point-of-care diagnostics, rising focus on sustainable medical packaging, expansion of molecular diagnostics testing, increasing investments in healthcare infrastructure, growing emphasis on supply chain safety and integrity. Major trends in the forecast period include increasing demand for sterile and contamination-resistant packaging, rising adoption of tamper-evident ivd packaging solutions, growing use of high-barrier plastic and glass materials, expansion of customized packaging for diagnostic kits, enhanced focus on regulatory-compliant packaging designs.

Global In Vitro Diagnostic Packaging Market Segmentation

1) By Packaging Type: Primary Packaging, Secondary Packaging, Tertiary Packaging 2) By Product: Bottles And Vials, Tubes, Petri Dishes, Closures, Other Products 3) By Material Type: Plastic, Glass, Metal, Composite Materials 4) By Application Area: Biochemistry, Microbiology, Immunology, Molecular Diagnostics 5) By End User: Hospitals, Laboratories, Academic Institutes, Other End Users Subsegments: 1) By Primary Packaging: Cartridges, Microplates, Sample Collection Containers, Reagent Reservoirs, Diagnostic Cassettes, Dropper Bottles 2) By Secondary Packaging: Folding Cartons, Paperboard Sleeves, Trays, Multi-Compartment Boxes, Label Sets, Instruction Leaflets 3) By Tertiary Packaging: Corrugated Shipping Boxes, Pallets, Insulated Shippers, Foam Inserts Or Cushioning, Tamper-Evident Seals, Bulk Transport Containers

What Is The Driver Of The In Vitro Diagnostic Packaging Market?

The rise in the incidence and prevalence of chronic diseases and infections is expected to propel the growth of the in vitro diagnostic (IVD) packaging market going forward. Chronic diseases and infections refer to long-lasting health conditions or diseases caused by pathogens that persist over time and often lead to long-term medical complications. The rise in the incidence and prevalence of chronic diseases and infections can be attributed to increasing exposure to pathogens, with lifestyle choices, particularly poor diet and lack of physical activity, being a significant factor. In vitro diagnostic (IVD) packaging addresses chronic diseases and infections by ensuring the safe, reliable, and efficient delivery of diagnostic tests that enable early detection and timely treatment, ultimately improving patient outcomes and healthcare efficiency. For instance, in March 2025, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the rise in the incidence and prevalence of chronic diseases and infections is driving the in vitro diagnostic packaging industry.

Key Players In The Global In Vitro Diagnostic Packaging Market

Major companies operating in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc, Corning Incorporated, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd., Thousand Peak Glass Bottle Co. Ltd., Gerresheimer AG, SCHOTT AG, Berry Global Inc., West Pharmaceutical Services Inc., SGD Pharma, Nipro Corporation

Global In Vitro Diagnostic Packaging Market Trends and Insights

Major companies operating in the in vitro diagnostic packaging market are focusing on developing innovative products such as the sustainable IVD packaging solution to enhance sustainability and reduce environmental impact in diagnostic product packaging. A sustainable IVD (in vitro diagnostic) packaging solution refers to the use of eco-friendly materials and practices in the packaging of diagnostic products, aimed at reducing environmental impact while maintaining product safety and integrity. For instance, in March 2025, Oxford Gene Technology IP Limited, a UK-based provider of diagnostic genomic solutions, introduced a new, environmentally sustainable packaging solution for its CytoCell product line. This innovative packaging utilizes biodegradable and recyclable materials, aligning with the increasing industry shift toward eco-friendly practices. The redesigned packaging not only supports a more sustainable approach to product disposal but also simplifies the process for laboratories with streamlined and accessible digital documentation. This move reinforces the company's commitment to reducing waste while improving operational efficiency in the clinical and diagnostic sectors.

What Are Latest Mergers And Acquisitions In The In Vitro Diagnostic Packaging Market?

In July 2023, STRATEC SE, a Germany-based provider of fully automated analyzer systems and complex consumables for in-vitro diagnostics, acquired Natech Plastics, Inc. for US$30 million plus an earn-out. Through this acquisition, STRATEC aims to enhance its IVD consumables and packaging capabilities by integrating Natech’s smart polymer-based consumables and expanding its portfolio of diagnostic consumables for medical technology and life sciences. Natech Plastics, Inc. is a US-based company that provides smart polymer-based consumables, including injection-molded parts and custom tubes, for in-vitro diagnostics and medical applications.

Regional Outlook

North America was the largest region in the in vitro diagnostic packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the In Vitro Diagnostic Packaging Market?

The in vitro diagnostic packaging market consists of sales of sterile containers, tamper-evident seals, temperature-controlled packaging, and moisture-resistant materials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.